Clinical Trial Update: A Double-blind "Preferred" Vardenafil Dose Study of QoL and Functional Outcomes in Males With Erectile Dysfunction [Phase 3]

View source ↗

Summary

A Phase 3, double-blind study evaluating a preferred vardenafil dosing strategy for erectile dysfunction to assess quality of life and functional outcomes has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Levitra (vardenafil)

Snippet

Sponsor: Bayer | Conditions: Erectile Dysfunction | Phase 3 | Status: COMPLETED